Standard

Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia. / Kanov, E. V.; Novozheeva, T. P.; Saratikov, A. S.

In: Eksperimental'naia i klinicheskaia farmakologiia, Vol. 65, No. 2, 2002, p. 56-58.

Research output: Contribution to journal › Article › peer-review

Harvard

Kanov, EV, Novozheeva, TP & Saratikov, AS 2002, 'Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia.', Eksperimental'naia i klinicheskaia farmakologiia, vol. 65, no. 2, pp. 56-58.

APA

Kanov, E. V., Novozheeva, T. P., & Saratikov, A. S. (2002). Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia. Eksperimental'naia i klinicheskaia farmakologiia, 65(2), 56-58.

Vancouver

Kanov EV, Novozheeva TP, Saratikov AS. Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia. Eksperimental'naia i klinicheskaia farmakologiia. 2002;65(2):56-58.

Author

Kanov, E. V. ; Novozheeva, T. P. ; Saratikov, A. S. / Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia. In: Eksperimental'naia i klinicheskaia farmakologiia. 2002 ; Vol. 65, No. 2. pp. 56-58.

BibTeX

@article{c4a153af8c5546a48fba0e6eb99bf341,
title = "Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia.",
abstract = "Pharmacokinetics of the new antiepileptic drug galodif was experimentally studied on rats. A single administration of the anticonvulsant is followed by slow elimination. A five-day administration leads to a significant acceleration of the drug elimination due to activation of the cytochrome P-450 dependent monooxygenase system of liver. After a 14-day administration, the elimination rate decreases as compared to that for the five-day treatment, while being still higher than in the case of single administration.",
author = "Kanov, {E. V.} and Novozheeva, {T. P.} and Saratikov, {A. S.}",
year = "2002",
language = "русский",
volume = "65",
pages = "56--58",
journal = "ЭКСПЕРИМЕНТАЛЬНАЯ И КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ",
issn = "0869-2092",
publisher = "Медицина",
number = "2",

}

RIS

TY - JOUR

T1 - Farmakokinetika galodifa pri razlichnoi prodolzhitel'nosti ego vvedeniia.

AU - Kanov, E. V.

AU - Novozheeva, T. P.

AU - Saratikov, A. S.

PY - 2002

Y1 - 2002

N2 - Pharmacokinetics of the new antiepileptic drug galodif was experimentally studied on rats. A single administration of the anticonvulsant is followed by slow elimination. A five-day administration leads to a significant acceleration of the drug elimination due to activation of the cytochrome P-450 dependent monooxygenase system of liver. After a 14-day administration, the elimination rate decreases as compared to that for the five-day treatment, while being still higher than in the case of single administration.

AB - Pharmacokinetics of the new antiepileptic drug galodif was experimentally studied on rats. A single administration of the anticonvulsant is followed by slow elimination. A five-day administration leads to a significant acceleration of the drug elimination due to activation of the cytochrome P-450 dependent monooxygenase system of liver. After a 14-day administration, the elimination rate decreases as compared to that for the five-day treatment, while being still higher than in the case of single administration.

UR - http://www.scopus.com/inward/record.url?scp=0036490937&partnerID=8YFLogxK

M3 - статья

C2 - 12109296

AN - SCOPUS:0036490937

VL - 65

SP - 56

EP - 58

JO - ЭКСПЕРИМЕНТАЛЬНАЯ И КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ

JF - ЭКСПЕРИМЕНТАЛЬНАЯ И КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ

SN - 0869-2092

IS - 2

ER -

ID: 99966910